IMRT in oral cavity cancer

@article{Studer2007IMRTIO,
  title={IMRT in oral cavity cancer},
  author={Gabriela Studer and Roger A Zwahlen and Klaus W. Graetz and Bernard J. Davis and Christoph Glanzmann},
  journal={Radiation Oncology (London, England)},
  year={2007},
  volume={2},
  pages={16 - 16}
}
BackgroundExcept for early T1,2 N0 stages, the prognosis for patients with oral cavity cancer (OCC) is reported to be worse than for carcinoma in other sites of the head and neck (HNC). The aim of this work was to assess disease outcome in OCC following IMRT.Between January 2002 and January 2007, 346 HNC patients have been treated with curative intensity modulated radiation therapy (IMRT) at the Department of Radiation Oncology, University Hospital Zurich. Fifty eight of these (16%) were… Expand
Follow up after IMRT in oral cavity cancer: update
TLDR
IMRT for R0-1 situations translated into a highly significant superior LRC and OAS compared to the IMRT cohort treated for macroscopic disease, found in patients treated for initial, as well as recurrent, disease. Expand
Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.
TLDR
In this single-institution series, postoperative IMRT was associated with promising LRC, OS, and lower late toxicity rates, and chemoradiotherapy was a successful treatment for patients with high-risk disease. Expand
Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control.
  • M. Daly, Q. Le, +7 authors D. Chang
  • Medicine
  • International journal of radiation oncology, biology, physics
  • 2011
TLDR
The predominant failure pattern was local, suggesting that both improvements in target delineation and radiosensitization and/or dose escalation are needed for local-regional control in SCC of the OC treated with IMRT with or without surgery. Expand
Outcome in recurrent head neck cancer treated with salvage-IMRT
TLDR
Calculated numbers of patients needed to treat with postoperative radiation after initial surgery, in order to avoid recurrence and tumor-specific death, suggest a rather generous use of adjuvant irradiation, usually with simultaneous chemotherapy. Expand
Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach
TLDR
Non-operative management of OSCC resulted in a meaningful rate of locoregional control, and could be an alternative curative approach when primary surgery would be declined, unsuitable or unacceptably delayed. Expand
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.
  • D. Gomez, J. Zhung, +9 authors N. Lee
  • Medicine
  • International journal of radiation oncology, biology, physics
  • 2009
TLDR
IMRT as an adjuvant treatment after surgical resection for oral cavity tumors is feasible and effective, with promising results and acceptable toxicity. Expand
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
TLDR
Postoperative IMRT following gross total surgical resection requires careful and comprehensive target volume delineation, and larger volumes may be needed than the primary RT setting. Expand
Concurrent Chemotherapy and Intensity-Modulated Radiotherapy for Organ Preservation of Locoregionally Advanced Oral Cavity Cancer
TLDR
Concurrent chemoIMRT results in promising locoregional control for oral cavity squamous cell carcinomas with acceptable toxicity in patients treated with concurrent chemotherapy and intensity-modulated radiotherapy (chemoIMRT). Expand
Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma
TLDR
LRRFS after postoperative IMRT is satisfying and toxicity is acceptable, and improvement of high-risk target volume definition especially in patients with flap reconstruction and ECE might transfer into better locoregional control. Expand
Outcome in Irradiated Oral Cavity Carcinoma: An Update
TLDR
A recent overview about outcome data in OCC treated in the modern IMRT era including presentation of the own single institution results is given. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 101 REFERENCES
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
  • N. Lee, P. Xia, +6 authors K. Fu
  • Medicine
  • International journal of radiation oncology, biology, physics
  • 2002
PURPOSE To update our experience with intensity-modulated radiotherapy (IMRT) in the treatment of nasopharyngeal carcinoma (NPC). METHODS AND MATERIALS Between April 1995 and October 2000, 67Expand
Multidisciplinary Approach in Advanced Cancer of the Oral Cavity: Outcome with Neoadjuvant Chemotherapy according to Intention-to-Treat Local Therapy
TLDR
In locally advanced squamous cell carcinoma of the oral cavity, neoadjuvant chemotherapy induces a high response rate that may facilitate definitive surgery or radiotherapy and patients have an acceptable long-term survival. Expand
[Oral squamous cell carcinoma Retrospective analysis of therapy results and prognosis by neoadjuvant, preoperative radio-chemotherapy].
TLDR
The charts of 129 patients treated for oral squamous cell carcinoma in the Department of Oral and Maxillofacial Surgery, University of Cologne, between 1995 and 2004 were investigated to show the therapeutic outcome and the survival rates for this regimen. Expand
Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
TLDR
Multivariate analysis showed that GTV and nGTV were independent risk factors determining locoregional control and disease-free survival for definitive oropharyngeal IMRT patients and are the most important factors predictive of therapeutic outcome. Expand
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
  • M. Kam, P. Teo, +6 authors A. Chan
  • Medicine
  • International journal of radiation oncology, biology, physics
  • 2004
TLDR
The authors' experience of using IMRT in the primary treatment of NPC showed a very high rate of locoregional control and favorable toxicity profile, and it was found that dose escalation above 66 Gy of IMRT-based therapy was a significant determinant of progression- free survival and distant metastasis-free survival for advanced T-stage tumors. Expand
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
TLDR
Intensity-modulated radiotherapy achieved encouraging local control rates in patients with oropharyngeal carcinoma and treatment toxicity was acceptable even in the setting of concurrent chemotherapy. Expand
IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients
TLDR
SIB-IMRT in HNC using 2.2 Gy per session is highly effective and safe with respect to tumor response and tolerance, and SIB with 2.1 Gy is not recommended for large tumors involving laryngeal structures. Expand
Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity.
TLDR
Patients who underwent salvage surgery with or without postoperative radiotherapy had significantly improved salvage and total survival times compared with patients who received chemotherapy and/or radiation therapy for their recurrence. Expand
Results of salvage treatment of the neck in patients with oral cancer.
  • L. Kowalski
  • Medicine
  • Archives of otolaryngology--head & neck surgery
  • 2002
TLDR
Patients undergoing previous neck dissection and with recurrences diagnosed after 6 months are not usually candidates for curative salvage treatment and are at a high risk for death. Expand
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
TLDR
Postoperative concurrent administration of high-dose cisplatin with radiotherapy is more efficacious than radiotherapy alone in patients with locally advanced head and neck cancer and does not cause an undue number of late complications. Expand
...
1
2
3
4
5
...